Evidence map›Paper›PMID 41807509›Full record

Trial reportScientific reports2026

GP perspectives on a computer-assisted strategy to support PPI deprescribing: a qualitative study.

Nele Kornder, Bettina Bücker, Alexandra Schmidt, Wiebke Reichert, Susanne Löscher, Michaela Maas, Anne Barzel, Annette Becker, Stefan Wilm, Annika Viniol and 1 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nele KornderDepartment of Primary Care, Marburg University, Karl-Von Frisch-Str. 4, 35043, Marburg, Germany. nele.kornder@uni-marburg.de.
Bettina BückerInstitute of General Practice (Ifam), Centre for Health and Society (Chs), Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Alexandra SchmidtChair of General Practice II and Patient-Centeredness in Primary Care, Institute of General Practice and Primary Care (IGPPC), Faculty of Health, Witten/Herdecke University, Witten, Germany.
Wiebke ReichertDepartment of Primary Care, Marburg University, Karl-Von Frisch-Str. 4, 35043, Marburg, Germany.
Susanne LöscherInstitute of General Practice (Ifam), Centre for Health and Society (Chs), Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Michaela MaasChair of General Practice II and Patient-Centeredness in Primary Care, Institute of General Practice and Primary Care (IGPPC), Faculty of Health, Witten/Herdecke University, Witten, Germany.
Anne BarzelDepartment of General Practice and Primary Care, Ulm University Hospital, Ulm, Germany.
Annette BeckerDepartment of Primary Care, Marburg University, Karl-Von Frisch-Str. 4, 35043, Marburg, Germany.
Stefan WilmInstitute of General Practice (Ifam), Centre for Health and Society (Chs), Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Annika ViniolDepartment of Primary Care, Marburg University, Karl-Von Frisch-Str. 4, 35043, Marburg, Germany.
Julia HeisigDepartment of Primary Care, Marburg University, Karl-Von Frisch-Str. 4, 35043, Marburg, Germany. julia.heisig@uni-marburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proton pump inhibitors (PPIs) are widely prescribed in primary care but often continued longer than clinically necessary, exposing patients to avoidable risks. Digital decision-support tools have been proposed to assist clinicians in identifying and managing potentially inappropriate medications. The arriba-PPI tool was developed to facilitate conversations on PPI deprescribing between general practitioners (GPs) and patients, supporting evidence-based and shared decision-making. To explore GPs' experiences with the arriba-PPI tool in clinical practice and understand factors influencing its use and impact on PPI prescribing and discontinuation. A qualitative exploratory study embedded within a multicentre cluster-randomised controlled trial conducted in German general practices. Semi-structured interviews were conducted with 26 GPs from the intervention arm who had used the tool. Interviews were analysed following Braun and Clarke's six-step thematic analysis methodology, applying a combined deductive-inductive approach. Six main themes emerged: perceived usefulness and acceptance of the tool; tool functionality and areas for improvement; patient perspectives and characteristics; doctor-patient interaction and consultation dynamics; PPI prescribing and discontinuation practices; and implementation context and long-term use. GPs valued the tool's structured format and visual aids for enhancing communication, particularly with patients reluctant to stop PPIs. Some described an educational benefit, reporting greater awareness and reflection on their own prescribing behaviour. Barriers to sustained use included technical issues, workflow integration challenges, and the absence of non-pharmacological alternatives. Trust and established doctor-patient relationships were seen as critical for successful deprescribing, often surpassing the tool's direct influence. While the arriba-PPI tool supports deprescribing conversations, its effectiveness depends on seamless integration, technical optimisation, and complementary non-drug strategies. Future digital interventions should follow established frameworks for complex intervention development, adopt a more holistic approach, and combine technological support with broader patient-centred care to achieve sustained deprescribing success in primary care.

Indexed as

DeprescriptionsGeneral PractitionersProton Pump InhibitorsAdultFemaleHumansMaleMiddle AgedPhysician-Patient RelationsQualitative ResearchProton Pump InhibitorsDecision support systemDeprescribingFamily medicineProton pump inhibitor

Identifiers

PMID41807509
PMCPMC12979569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.